Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Patient Information Leaflet last updated on the eMC: 09/08/2011
PIL SANDIMMUN Concentrate for Solution for infusion 50mg/ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 14/12/2010 and displayed until 09/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 03/12/2009 and displayed until 14/12/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 11/09/2008 and displayed until 03/12/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 18/04/2008 and displayed until 11/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 01/02/2008 and displayed until 18/04/2008
Reasons for adding or updating:
  • Change of contra-indications
  • Change due to user-testing of patient information
Updated on 27/01/2005 and displayed until 01/02/2008
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 26/08/2004 and displayed until 27/01/2005
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 12/02/2003 and displayed until 26/08/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 02/01/2001 and displayed until 12/02/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ciclosporin